Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation (Q39807470)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

title

Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

main subject

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author

Gianluigi Giannelli

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

author name string

Antonio Mazzocca

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

Emilia Fransvea

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

Gabriela Lavezzari

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

Salvatore Antonaci

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

published in

Hepatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

volume

50

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

page(s)

1140-1151

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

cites work

Updated treatment approach to hepatocellular carcinoma.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorafenib in advanced hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiogenesis and hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of vascular endothelial growth factor in human hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of transforming growth factor-beta 1 in the urine of patients with hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein microarrays: meeting analytical challenges for clinical applications.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative predictors of vascular invasion in hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A sweet link between TGFbeta and vascular disease?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The complex pattern of SMAD signaling in the cardiovascular system

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.23118

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/HEP.23118

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

Fatcat ID

release_52ohi6nonzamtghqhs2zccin4i

0 references

PubMed publication ID

19711426

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19711426

retrieved

14 September 2017

ResearchGate publication ID

26771364

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39807470&oldid=2090647446"